Automations
This pillar addresses privacy-preserving data generation workflows that create statistically realistic synthetic patient records, scans, and cohorts for research and model development. Content should cover fidelity validation, rare disease data augmentation, governance controls, and how synthetic data pipelines expand experimentation without exposing protected health information.
This foundational workflow automates the end-to-end creation of privacy-preserving synthetic patient cohorts, from data ingestion and statistical modeling to validation and secure delivery. It eliminates the manual bottleneck of data procurement, enabling R&D teams to generate unlimited, compliant datasets for faster hypothesis testing and model development. The architecture combines generative AI agents, differential privacy controls, and automated fidelity scoring, with implementation focusing on integration with existing EHR and research platforms.
This workflow automates the rapid creation of statistically matched synthetic control arms for clinical trials, reducing reliance on costly and slow-to-recruit real-world placebo groups. It accelerates trial design and feasibility studies by generating compliant, high-fidelity patient cohorts that preserve treatment-effect signals. Implementation involves orchestrating generative models with trial protocol logic and integrating outputs directly into Clinical Trial Management Systems (CTMS) for seamless adoption.
This specialized workflow automates the generation of synthetic patients with rare diseases to overcome the critical data scarcity that stalls research and drug development. It creates statistically valid, privacy-safe cohorts that enable robust model training and clinical trial simulation where real data is insufficient. The architecture uses conditional generative models and multi-agent validation to ensure clinical plausibility, with implementation focused on augmenting real-world datasets in biopharma R&D environments.
This workflow automates the generation of high-fidelity synthetic medical imaging data (e.g., MRI, CT, X-ray) with preserved pathological findings and anatomical variability. It addresses the bottleneck of acquiring annotated, diverse medical images for training diagnostic AI, reducing dependency on scarce and sensitive real scans. The solution uses a multi-agent system for modality-specific generation, quality assurance, and DICOM metadata creation, designed for integration with PACS and AI development platforms.
This critical workflow automates the continuous validation of synthetic data against real-world statistical distributions, clinical logic, and privacy guarantees. It replaces manual, sample-based checks with an agentic system that scores fidelity, detects anomalies, and flags cohorts that fail predefined quality thresholds. Implementation involves building a validation layer with automated metrics (e.g., KS tests, propensity score metrics) that gates data release to downstream research and development teams.
This compliance-centric workflow automates the assessment of re-identification risk in synthetic datasets before they are shared or published. It systematically tests synthetic cohorts against known privacy attack vectors, ensuring they meet k-anonymity, l-diversity, and differential privacy standards required by HIPAA and GDPR. The architecture combines risk simulation agents with governance rules, providing auditable reports that accelerate data sharing agreements and IRB approvals.
This workflow automates the creation of synthetic 'starter' datasets or 'canaries' used to initialize and validate federated learning models across decentralized healthcare institutions. It solves the cold-start and alignment problem in federated networks by providing a common, privacy-safe data foundation. Implementation focuses on generating schema-aligned synthetic data that preserves cross-site statistical properties, enabling faster consortium setup and more reliable distributed model training.
This workflow automates the governance and operational process of requesting, approving, and delivering synthetic datasets to internal researchers and external partners. It replaces manual, ticket-based provisioning with a self-service portal where agents validate requests against data use agreements, apply appropriate masking, and trigger generation or delivery pipelines. The architecture integrates with IAM systems and data catalogs, dramatically reducing the time from data request to actionable insight.
This workflow automates the generation of dynamic, longitudinal synthetic patient data streams for driving high-fidelity healthcare simulations used in training, operational planning, and system stress-testing. It creates interactive digital patient cohorts that respond to simulated interventions, providing a risk-free environment for testing clinical protocols or hospital workflows. Implementation involves integrating synthetic data engines with discrete-event simulation and digital twin platforms.
This MedTech-focused workflow automates the creation of synthetic medical imaging data specifically formatted and annotated for regulatory package submissions to bodies like the FDA. It generates the volume and variety of scan data needed to demonstrate algorithm efficacy without sharing patient PHI, accelerating the regulatory pathway for AI-based devices. The architecture ensures synthetic DICOMs include necessary metadata and clinical findings, integrated with submission assembly platforms.
This workflow automates the generation of synthetic healthcare claims data that mirrors real billing patterns, including sophisticated fraud schemes, for training and stress-testing detection algorithms. It enables health insurers to develop more robust fraud models without exposing real member data or waiting for sufficient fraudulent examples to occur. The solution uses generative adversarial networks and rule-based agents to create plausible claim sequences, diagnosis codes, and provider networks.
This workflow automates the provisioning of tailored, privacy-safe synthetic datasets into isolated research sandboxes for academic medical centers and universities. It eliminates the lengthy data access and IRB process for student projects, allowing immediate, compliant access to realistic patient data for thesis work and method development. Implementation involves a portal where faculty define cohort parameters, triggering automated generation and deployment into secure computational environments.
This workflow automates the complex ETL and transformation process required to convert sensitive real-world datasets into fully synthetic, schema-consistent alternatives. It handles data type conversion, relationship preservation, and clinical coding system consistency, removing the manual data engineering bottleneck. The architecture uses specialized agents for schema analysis, relationship mapping, and generative model training, ensuring the synthetic output is directly usable in existing analytical pipelines.
This workflow automates the end-to-end pipeline for generating modality-specific synthetic medical images, complete with pathologies, annotations, and realistic noise artifacts. It provides a scalable source of training data for computer vision models in radiology, reducing dependency on scarce, labeled real images. The implementation details how to orchestrate GANs or diffusion models, integrate radiologist-in-the-loop validation, and export in standard formats for PACS and AI platforms.
This workflow automates the generation of high-frequency, longitudinal synthetic data from wearables and CGMs, capturing realistic physiological patterns, events (e.g., hypo/hyperglycemia), and sensor artifacts. It enables digital health companies and researchers to develop and validate algorithms without accessing real patient streams, accelerating product development. The architecture involves time-series generative models and agent-based validation for clinical plausibility.
This advanced analytics workflow automates the generation of synthetic cohorts specifically designed for causal inference and counterfactual modeling, where understanding 'what-if' scenarios is critical. It creates patient records with known underlying treatment effects, enabling researchers to validate and benchmark causal estimation methods in a controlled, transparent setting. Implementation focuses on integrating synthetic data generation with causal graph frameworks and econometric model testing platforms.
This business workflow automates the use of synthetic data as a negotiating and prototyping tool in data sharing agreements between healthcare entities. It generates representative synthetic datasets that allow potential partners to assess data utility and feasibility without legal or privacy hurdles, shortening deal cycles from months to weeks. The architecture includes rapid cohort generation based on metadata and automated report generation on dataset fitness for purpose.
This workflow automates the on-demand generation of synthetic training, validation, and test sets throughout the MLops lifecycle for healthcare AI teams. It addresses the chronic data shortage that stalls model iteration, allowing data scientists to spin up tailored datasets for specific development stages instantly. The solution integrates synthetic data pipelines with version control, experiment tracking, and model registry systems to create a seamless, data-abundant development environment.
This cross-functional workflow automates the creation and governance of a unified synthetic data asset that serves both R&D (for trial design) and Commercial teams (for market access and forecasting). It breaks down data silos by providing a single, compliant source of truth that reflects the patient population, enabling aligned strategic decisions. Implementation involves multi-department requirement gathering, synthetic data generation with commercial variables (e.g., payer mix), and access-controlled distribution.
This operational workflow automates the monitoring, alerting, and tuning of production synthetic data generation pipelines. It tracks key metrics like generation speed, statistical fidelity drift, compute cost, and failure rates, using agents to diagnose issues and trigger retraining or scaling actions. This ensures reliable, cost-effective delivery of synthetic data assets, with implementation detailing integration with observability platforms like Datadog and cloud cost management tools.
This workflow automates the comprehensive logging, lineage tracking, and policy enforcement for all synthetic data assets across their lifecycle. It creates an immutable audit trail covering data origins, generation parameters, access events, and downstream usage, which is essential for regulatory compliance and internal governance. The architecture uses agents to inject metadata, enforce retention policies, and generate compliance reports, integrating with enterprise data catalogs.
This workflow automates the assembly of documentation and evidence packets for IRB submissions that propose the use of synthetic data, or that use synthetic data to justify a reduced-risk protocol. It drastically cuts the administrative time for researchers by auto-generating data descriptions, privacy risk assessments, and fidelity reports. Implementation involves templating systems, integration with IRB submission portals, and LLM-assisted drafting of protocol narratives.
This workflow automates the creation of synthetic clinical narrative text—such as progress notes, discharge summaries, and radiology reports—that are coherent, medically accurate, and stylistically realistic. It solves the data scarcity for NLP model training in healthcare while preserving patient privacy. The architecture uses LLMs fine-tuned on medical corpora, constrained by clinical knowledge graphs and agentic validation for factual consistency, with outputs formatted for major EHR systems.
This workflow automates the generation of synthetic patient records featuring multiple, interacting chronic conditions (comorbidities) that reflect real-world clinical complexity. It enables research into disease interactions and polypharmacy where real data with specific condition combinations is rare. The solution uses graph-based models to represent disease relationships and agentic logic to enforce physiological plausibility, directly supporting epidemiological studies and care pathway design.
This workflow automates the seamless flow of synthetic patient data into clinical trial Electronic Data Capture systems like Medidata Rave or Oracle Clinical for testing, training, and demos. It eliminates the manual entry or clumsy import of test data, ensuring synthetic cohorts populate EDC forms with valid, consistent clinical values. Implementation involves building connectors that map synthetic data schemas to EDC case report forms and handle validation rules.
This workflow automates the generation of synthetic cohorts with controlled distributions across sensitive attributes (race, gender, age) to stress-test healthcare AI models for bias and fairness. It enables developers to proactively identify and mitigate algorithmic bias before deployment, using data that can be crafted to expose edge cases. The architecture provides a framework for defining fairness scenarios, generating the corresponding data, and running automated bias audits.
This workflow automates the generation of synthetic adverse event reports, including patient demographics, drug exposures, timelines, and outcome narratives, for pharmacovigilance system testing and model training. It allows pharma safety teams to develop and validate signal detection algorithms without waiting for real reports, which are sparse and sensitive. The solution ensures synthetic events follow known drug-side effect relationships and reporting formats like ICSR.
This workflow automates the creation of synthetic patient lifelines—longitudinal records that simulate a patient's journey through the healthcare system over time, including diagnoses, treatments, and outcomes. It is critical for outcomes research and predictive modeling where temporal dynamics are key. The architecture uses agent-based simulation to model disease progression and care pathways, generating timestamped event sequences that can be ingested into observational health databases like OMOP.
This precision medicine workflow automates the generation of synthetic patient cohorts defined by specific biomarker statuses (e.g., EGFR+, PD-L1 high) for targeted therapy research and companion diagnostic development. It creates the large, tailored datasets needed to study rare molecular subgroups without the prohibitive cost and time of patient recruitment. Implementation involves conditional generation models tied to biomarker prevalence data and integration with genomic data platforms.
This validation workflow automates a rigorous, multi-method cross-validation process to ensure synthetic cohorts are fit for their intended analytical purpose (e.g., prediction, causal inference). It goes beyond basic statistical checks by running a battery of analytical models on both synthetic and real data, comparing performance to flag utility degradation. The system uses orchestration to manage these computational experiments and provide a clear 'fitness-for-use' score to data consumers.
How We Work
One-fit-all AI don't work for modern businesses. At Inferensys, we aim to understand your business & custom requirements; which we use to define most efficient agentic workflows, the data, and the tools for your business.
01
We understand the task, the users, and where AI can actually help.
Read more02
We define what needs search, automation, or product integration.
Read more03
We implement the part that proves the value first.
Read more04
We add the checks and visibility needed to keep it useful.
Read moreThe first call is a practical review of your use case and the right next step.
Talk to Us
